… and risks of vasopressin use in the setting of septic shock and vasoplegic shock following …
the current indications for vasopressin and its agonists in the setting of septic shock, and the …

… -line vasopressin analogues in septic shock patients and … vasopressin [ 42–44 ], we
performed a randomized controlled trial to compare the efficacy and safety of arginine vasopressin (…

… from the Vasopressin and Septic Shock Trial (VASST), a randomized trial of vasopressin
versus norepinephrine in septic shock. Relevant literature regarding vasopressin and other …

… , a vasopressin analog, have been studied recently for the treatment of septic shock.
When administered as a 1–2 mg intravenous dose in patients with septic shock, terlipressin …

… Most existing non-IPD meta-analyses assess not only vasopressin but also its analogues …
We found vasopressin therapy in septic shock had no effect on 28-day mortality although the …

… Vasopressin (antidiuretic hormone) is emerging as a potentially major advance in the … of
septic shock. Terlipressin (tricyl-lysine-vasopressin) is the synthetic, long-acting analogue of …

… septic shock patients and potentially require limb amputation.36, 37 Skin ischemia may either
occur as a complication of septic shock … effect of vasopressin analogues in septic shock, it …

… cessation of vasopressin treatment in septic shock is often prevented with the use of terlipressin
( 57, 95 ), an analogue with greater selectivity for V 1 Rs over V 2 Rs (2.2 vs. 1) ( 57, 96 ). …

… In addition to the optimal information size, an adjusted boundary line for favoring vasopressin
or its analogue use and an adjusted boundary line for favoring catecholamine use alone …

… However, significant heterogeneity in the studies existed, and the lower incidence of AKI
and use of RRT with vasopressin analogues was lost in the septic shock patients. …